Get started
Author

Jone Alberdi-Ballina

Observed name: J. Alberdi‐Ballina
ORCID: 0000-0003-0486-5936
Observed ORCID: 0000-0003-0486-5936
OpenAlex ID: A5115632002
543 | Obinutuzumab‐induced Adcc as a Predictor of Minimal Residual Disease in Chronic Lymphocytic Leukemia: a Preliminary Study
2025 · R. García‐Muñoz, S. Rincon‐Lopez, et al. · Hematological Oncology · 2
PDF
SOX4 in chronic lymphocytic leukaemia: the forgotten transcription factor
2025 · Ricardo García-Muñoz, Jone Alberdi-Ballina, et al. · Blood Research · 1
PDF
510 | the Antibody‐dependent Cellular Cytotoxicity and Metabolic Tumor Volume Balance: a Novel Predictive Marker for Tumor Recurrence in Diffuse Large B‐cell Lymphoma
2025 · S. Rincon‐Lopez, P. Garrastachu‐Zumaran, et al. · Hematological Oncology
PDF
High NK Cell Levels at the End of Obinutuzumab Treatment Are Associated with Negative Minimal Residual Disease (MRD) in Chronic Lymphocytic Leukemia (CLL)
2025 · Ricardo García-Muñoz, Javier Larreina-Pérez, et al. · Research Square
PDF
Mujer de 77 años con lumbalgia, astenia y plaquetopenia
2024 · Ada Esteban-Figuerola, Andrea Campeny-Najara, et al. · Revista Sangre
PDF
Works count: 5
Citation count: 3
H-index: 1
I10-index:
Year
Topic
Type